Dynamic changes of live/apoptotic circulating tumour cells as predictive marker of response to Sunitinib in metastatic renal cancer

Clinical Evaluation of M30 and M65 ELISA Cell Death Assays as Circulating Biomarkers in a Drug-Sensitive Tumor, Testicular Cancer

(2015) Esther C. de Haas et al.   NEOPLASIA

High independent prognostic and predictive value of circulating tumor cells compared with serum tumor markers in a large prospective trial in first-line chemotherapy for metastatic breast cancer patients

(2011) J.- Y. Pierga et al.   ANNALS OF ONCOLOGY

Hypertension as a Biomarker of Efficacy in Patients With Metastatic Renal Cell Carcinoma Treated With Sunitinib

(2011) B. I. Rini et al.   JNCI-Journal of the National Cancer Institute

Clinical value of circulating endothelial cells and circulating tumor cells in metastatic breast cancer patients treated first line with bevacizumab and chemotherapy

(2010) F.- C. Bidard et al.   ANNALS OF ONCOLOGY

Prognostic factors for progression-free and overall survival with sunitinib targeted therapy and with cytokine as first-line therapy in patients with metastatic renal cell carcinoma

(2010) S. Patil et al.   ANNALS OF ONCOLOGY

Changes in Circulating Tumor Cell Detection in Patients with Localized Breast Cancer Before and After Surgery

(2010) Maria T. Sandri et al.   ANNALS OF SURGICAL ONCOLOGY

Detection of minimal residual disease in blood and bone marrow in early stage breast cancer

(2010) Savitri Krishnamurthy et al.   CANCER

Sunitinib Acts Primarily on Tumor Endothelium rather than Tumor Cells to Inhibit the Growth of Renal Cell Carcinoma

(2010) D. Huang et al.   CANCER RESEARCH

EpCAM in carcinogenesis: the good, the bad or the ugly

(2010) B. T. F. van der Gun et al.   CARCINOGENESIS

M30 Neoepitope Expression in Epithelial Cancer: Quantification of Apoptosis in Circulating Tumor Cells by CellSearch Analysis

(2010) E. Rossi et al.   CLINICAL CANCER RESEARCH

The tumor-associated EpCAM regulates morphogenetic movements through intracellular signaling

(2010) Nadim Maghzal et al.   JOURNAL OF CELL BIOLOGY

Accelerated Metastasis after Short-Term Treatment with a Potent Inhibitor of Tumor Angiogenesis

(2009) John M.L. Ebos et al.   CANCER CELL

Antiangiogenic Therapy Elicits Malignant Progression of Tumors to Increased Local Invasion and Distant Metastasis

(2009) Marta Pàez-Ribes et al.   CANCER CELL

Sunitinib Inhibition of Stat3 Induces Renal Cell Carcinoma Tumor Cell Apoptosis and Reduces Immunosuppressive Cells

(2009) H. Xin et al.   CANCER RESEARCH

Efficacy and Safety of Pazopanib in Patients With Metastatic Renal Cell Carcinoma

(2009) Thomas E. Hutson et al.   JOURNAL OF CLINICAL ONCOLOGY

Circulating and Disseminated Tumor Cells in the Clinical Management of Breast Cancer Patients: Unanswered Questions

(2009) A. Amadori et al.   ONCOLOGY

Circulating tumor cells in colorectal cancer: correlation with clinical and pathological variables

(2008) J. Sastre et al.   ANNALS OF ONCOLOGY

Can Tyrosine Kinase Inhibitors be Discontinued in Patients with Metastatic Renal Cell Carcinoma and a Complete Response to Treatment? A Multicentre, Retrospective Analysis

(2008) Manfred Johannsen et al.   EUROPEAN UROLOGY